Amgen's weight-loss drug MariTide had a successful Phase 2 trial so the company is expanding development plans to study its use for heart disease and sleep apnea.

Amgen (NASDAQ:AMGN) today announced full results from Part 1 of the Phase 2 study of MariTide (maridebart cafraglutide, formerly AMG 133), a long-acting, peptide-antibody conjugate subcutaneously ...

Kelsey Sharma, a nurse practitioner based in Minnesota, presents her research on the relationship between OSA, GERD, and IBD ...

Happy Health has announced that the U.S. Food and Drug Administration has cleared the Happy Ring as a class II medical device to facilitate the diagnosis of obstructive sleep apnea, insomnia and other ...

Everyone knows the feeling: tossing and turning during a hot, sticky night when sleep feels impossible.

Over 104 million Indians suffer from obstructive sleep apnea, a common condition causing loud snores. This disorder has a ...

A personal crossword that should be less difficult to solve than my recent diagnosis.

The clinical syndrome of obstructive sleep apnea (OSAS) in children is a distinct, yet somewhat overlapping disorder with the condition that occurs in adults, such that the clinical manifestations ...

Lake Cumberland Regional Hospital (LCRH) is proud to announce a major milestone in sleep apnea treatment, as Dr. Andrew ...

The cannabinoid industry is transitioning from early-stage exploration to scientifically validated, regulatory-backed ...

New data from a Phase 3 trial show that the daily anti-obesity pill may be as safe and effective as drugs like Mounjaro and ...

Up to 50% of all adults snore occasionally, while for half of them it could be a sign of a sleep disorder, such as ...